The combination of PD-1/PD-L1 inhibitors with a variety of different drugs was also associated with pneumonitis risk, indicating the superposition effect of multiple drugs on pulmonary toxicity (10, 17, 31, 45, 46). The gene discussed is PDCD1; the disease is pneumonitis.